Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 494 Results

Page 28 of 50« First «...10 20...26 272829 30...40 50...»Last »

March 23, 2018

DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

March 21, 2018

DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

March 20, 2018

DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares

March 16, 2018

DBV Technologies Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F

March 14, 2018

DBV Technologies Reports Full Year 2017 Financial Results

March 7, 2018

DBV Technologies to Present at the Barclays Global Healthcare Conference

February 26, 2018

DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

February 20, 2018

DBV Technologies Reports December 31, 2017 Cash Position

February 14, 2018

DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut

February 12, 2018

DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress

Page 28 of 50« First «...10 20...26 272829 30...40 50...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Your California Privacy Rights

Scroll to Top